Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

Sen. Bernie Sanders grilled Novo Nordisk's CEO Lars Jorgensen over the cost of the company's weight loss and diabetes ...

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...

A key study used in securing FDA approval for Wegovy as a lifetime medication for weight loss was based on patients using the ...

An emerging market for compounded weight loss injections that mimic brand-name drugs such as Ozempic, Wegovy, Mounjaro and ...

Despite being patented products without any approved generics, sky-high demand for GLP-1 drugs like Ozempic and Mounjaro has ...

Epitomee Medical (TASE: EPIT), chaired by serial biomed entrepreneur Shimon Eckhouse, has announced the receipt of US Federal ...

The U.S. Food and Drug Administration (FDA) has approved seven medications for weight loss and management. These medications typically help you control your appetite or help your body respond to ...